داروسازی روز دارو
دروز | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/08/18 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/18 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 263.077 Billion | 967.845 Billion | |
Income Taxes Paid | -91.973 Billion | -11.228 Billion | |
Net Cash Flow from Operating Activities | 171.104 Billion | 956.617 Billion | |
Purchases of Property, Plant and Equipment | -24.87 Billion | -24.87 Billion | |
Dividends Received | 7.388 Billion | 7.388 Billion | |
Cash Received from Income on Other Investments | 477 Million | 477 Million | |
Net Cash Flow from Investing Activities | -17.005 Billion | -17.005 Billion | |
Net Cash Flow before Financing Activities | 154.099 Billion | 939.612 Billion | |
Cash Received from Borrowings | 8.79 Trillion | 8.706 Trillion | |
Repayments of Borrowings (Principal) | -7.804 Trillion | -7.717 Trillion | |
Interest Paid on Borrowings | -1.331 Trillion | -1.331 Trillion | |
Net Cash Flow from Financing Activities | -345.139 Billion | -342.291 Billion | |
Net Increase (Decrease) in Cash | -191.04 Billion | 597.321 Billion | |
Cash at Beginning of Period | 335.267 Billion | 335.267 Billion | |
Effect of Exchange Rate Changes | 24.187 Billion | -764.174 Billion | |
Cash at End of Period | 168.414 Billion | -428.907 Billion | |
Non-Cash Transactions | 679.48 Billion | 679.48 Billion |